PX-12
99%
- Product Code: 102184
CAS:
141400-58-0
Molecular Weight: | 188.31 g./mol | Molecular Formula: | C₇H₁₂N₂S₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD18086851 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
PX-12 is primarily investigated for its potential applications in cancer therapy. It functions as an inhibitor of thioredoxin-1 (Trx-1), a protein that plays a crucial role in cancer cell survival and proliferation. By inhibiting Trx-1, PX-12 disrupts the redox balance within cancer cells, leading to increased oxidative stress and ultimately inducing cell death. This mechanism makes it a promising candidate for targeting various types of cancers, particularly those that are resistant to conventional treatments. Additionally, PX-12 has shown potential in reducing tumor growth in preclinical studies, making it a subject of interest for further clinical development. Its ability to enhance the efficacy of other anticancer therapies when used in combination is also being explored.
Product Specification:
Test | Specification |
---|---|
Appearance | Solid |
Purity (%) | 98.5-100 |
Proton Nmr Spectrum | Conforms To Structure |
Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿2,980.00 |
+
-
|
0.025 | 10-20 days | ฿9,170.00 |
+
-
|
0.100 | 10-20 days | ฿24,120.00 |
+
-
|
PX-12
PX-12 is primarily investigated for its potential applications in cancer therapy. It functions as an inhibitor of thioredoxin-1 (Trx-1), a protein that plays a crucial role in cancer cell survival and proliferation. By inhibiting Trx-1, PX-12 disrupts the redox balance within cancer cells, leading to increased oxidative stress and ultimately inducing cell death. This mechanism makes it a promising candidate for targeting various types of cancers, particularly those that are resistant to conventional treatments. Additionally, PX-12 has shown potential in reducing tumor growth in preclinical studies, making it a subject of interest for further clinical development. Its ability to enhance the efficacy of other anticancer therapies when used in combination is also being explored.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :